Tuesday, October 2, 2018

Amerisource Inks $625M FCA Deal In 'Sham Pharmacy' Row

Law360-11 hours ago
According to the DOJ, the company was a "sham pharmacy" that often didn't bother to obtain valid prescriptions, instead labeling drugs with the names of staff
Post a Comment